Bayer Spends Up to $4 Billion for AskBio’s Gene Therapies

Drugmakers including Novartis, Roche Holding and Bristol-Myers Squibb have snapped up makers of gene therapies because they offer potential to cure a wide range of often-rare diseases by replacing or repairing errors in the body’s instruction manual.

Leave a Comment